Abstract
A 56 year old postmenopausal patient underwent a right radical mastectomy for a stage I breast cancer. An adjuvant treatment with tamoxifen was planned, but, because of patient's choice, a regular administration of the endocrine treatment started only one year after the operation. After a very short period of drug administration, she developed a steroid responsive nephrotic syndrome. We have reviewed the international literature concerning drug-induced renal disease; this is the first case of a tamoxifen-induced nephrotic syndrome.
| Original language | English |
|---|---|
| Pages (from-to) | 2171-2172 |
| Number of pages | 2 |
| Journal | Anticancer Research |
| Volume | 14 |
| Issue number | 5 B |
| Publication status | Published - 1994 |
Keywords
- Breast cancer
- Endocrine treatment
- Nephrotic syndrome
ASJC Scopus subject areas
- Cancer Research
- Oncology
Fingerprint Dive into the research topics of 'Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer case report and review of the literature'. Together they form a unique fingerprint.
Cite this
Lauro, S., Lalle, M., Andrea, M. R. D., Vecchione, A., & Frati, L. (1994). Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer case report and review of the literature. Anticancer Research, 14(5 B), 2171-2172.